Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03826693

Efficacy of Nitrous Oxide in OCD: Pilot Study

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
45 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.

Detailed description

Obsessive-compulsive disorder (OCD) is a chronic and disabling disorder characterized by recurrent intrusive thoughts and associated compulsive behaviors that is estimated to affect more than 3 million individuals in the US each year. This study seeks to explore whether a single inhalation of nitrous oxide gas may bring about rapid symptom relief in OCD.

Conditions

Interventions

TypeNameDescription
DRUGNitrous OxideOCD participants in this arm will receive 50%oxygen/50% nitrous oxide admixture for 60 minutes.
DRUGNitrogenOCD participants in this arm will receive 50%oxygen/50% nitrogen admixture for 60 minutes.

Timeline

Start date
2021-04-17
Primary completion
2026-09-01
Completion
2027-10-01
First posted
2019-02-01
Last updated
2025-08-27

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03826693. Inclusion in this directory is not an endorsement.